SEC Filing Summary: CNO Financial Group, Inc. (Form 13F)
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by CNO Financial Group, Inc. for the reporting period ending June 30, 2015. The document discloses the institutional investment manager's holdings of equity securities and certain debt securities as of the end of the quarter.
Key Financial Metrics and Holdings
The filing details specific portfolio positions rather than the company's own financial performance (revenue, profit, or cash flow). The total value of reported holdings is not explicitly summed in the text, but individual positions are listed with values in thousands of dollars.
| Issuer | Security Type | Value ($000s) | Shares/Principal |
|---|---|---|---|
| SPDR S&P 500 ETF TR | ETF | 116,475 | 565,825 |
| ISHARES TR CORE US AGGBD ET | ETF | 102,525 | 942,500 |
| WELLPOINT INC | Note 2.750% | 3,292 | 1,500,000 |
| GILEAD SCIENCES INC | Note 1.625% | 2,578 | 500,000 |
| DANAHER CORP DEL | Note 1/2 | 2,484 | 1,000,000 |
| BRISTOL MYERS SQUIBB CO | DBCV 9/1 | 1,667 | 1,000,000 |
| HEALTH CARE REIT INC | Note 3.000% | 1,609 | 1,250,000 |
| FORD MTR CO DEL | Common Stock | 1,314 | 87,514 |
| ASPEN INSURANCE HOLDINGS LTD | Common Stock | 478 | 9,977 |
| INGERSOLL-RAND PLC | Common Stock | 533 | 7,911 |
| CMS ENERGY CORP | Common Stock | 279 | 8,756 |
| ALLEGION PUB LTD CO | Common Stock | 159 | 2,637 |
| HEALTH CARE REIT INC | Common Stock | 125 | 1,910 |
| SPDR SERIES TRUST BRC HGH YLD BD | ETF | 922 | 24,000 |
| VANGUARD WHITEHALL FDS INC | High Div Yld | 3,201 | 47,550 |
| VANGUARD INTL EQUITY INDEX F | FTSE Europe ETF | 2,456 | 45,500 |
| ISHARES TR IBOXX INV CP ETF | ETF | 4,629 | 40,000 |
| E M C CORP MASS | Common Stock | 510 | 19,329 |
Material Changes and Voting Authority
The filing does not provide comparative data against the prior quarter (March 31, 2015) to determine material changes in holdings. All listed securities are reported with Sole voting authority and None shared or none voting authority. The investment manager is identified as "DFND" (likely CNO Financial Group's investment management arm) for all positions.
Guidance, Outlook, and Risks
As a Form 13F, this document contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a statutory disclosure of holdings only.
Key Facts for Investor Verification
- Portfolio Composition: The portfolio is heavily weighted toward broad market ETFs (SPDR S&P 500 and iShares Core US Aggregate Bond) and investment-grade corporate debt notes.
- Top Holdings: The two largest positions by value are the SPDR S&P 500 ETF ($116.5M) and the iShares Core US Aggregate Bond ETF ($102.5M).
- Debt Exposure: Significant holdings in corporate notes from WellPoint, Gilead Sciences, Danaher, Bristol Myers Squibb, and Health Care REIT.
- Reporting Limitation: This filing does not disclose the total assets under management, the company's own financial health, or any derivatives not listed in the table.